NYTimes article on Hope
Submitted by katepolcari on Mon, 2006-01-02 09:21.
In the New York Times,Dec.24th, there is a front page article on patients. In the piece, Elissa Levy, an MS patient is profiled. She has secondary progressive MS. It describes her being treated with a drug widely available in Europe but not in the U.S. Her response has been dramatic. What is this drug available in Europe but not here? The article does not name the medication unfortunately.


Hormones and MS
the drug
This bulletin board
reads:
I got this email from NYTimes this morning: "To all of you who read my article about the ethics of hope, and inquired about the drug taken by the MS patient at the end of the story: here is the substance of an email she sent me with information that she is permitting me to pass on to you. Please read it carefully!
Wishing you a New Year full of hope and healing,
Jan Hoffman
From patient: The new medication I am on is called 4-aminopyridine and they are in the process of doing trials with MS patients and spinal injury patients. The drug has been available for a long time in Europe. I am currently getting the 4-AP from a compounding pharmancy (College Pharmacy) in Colorado. Even though the medication is not FDA approved, all the ingredients are, so this pharmacy mixes them together and sends them to you. You just need a prescription from a doctor. Health insurance does not cover 4-AP so it costs about $75 per month. There are more risks since it is not controlled. The most serious side effect that has occurred in the trials is seizures. The seizures were at the higher doses so I am taking a smaller dose but it is still working unbelievably. If you receive any questions about the drug please pass on this information and tell those who are interested to speak with their doctors. If their doctors have questions they can call my doctor, Dr. Mark Tullman, at the Columbia MS Center at 212-342-8647. Following are a couple of links to more information.
one
the other
Re:the drug
Re:the drug
Re:the drug
Google provides the answer (maybe)
Re:Google provides the answer (maybe)